InvestorsHub Logo
Followers 22
Posts 3527
Boards Moderated 0
Alias Born 10/15/2016

Re: exwannabe post# 39548

Wednesday, 06/30/2021 12:11:53 PM

Wednesday, June 30, 2021 12:11:53 PM

Post# of 43784
This one had the tidbit

https://www.onclive.com/view/leukocyte-interleukin-plus-soc-without-chemo-provides-5-year-os-benefit-of-14-1-in-head-and-neck-cancer


Specifically, the 3-year OS rate with Multikine plus cyclophosphamide, indomethacin, and zinc-multivitamins (CIZ) and SOC was 72.4% vs 78.8% with Multikine (no CIZ) and SOC, and 67.5% with SOC alone. The 5-year OS rates in these groups were 62.7% vs 55.5% vs 48.6%, respectively. The primary survival comparison was predefined to examine only the first and last groups.



C in CiZ is mustard gas Cisplatin


... granted that is not exactly chemo-therapy in this form, but it is still remarkably suggestive that MK doesn't like to work with Cisplatin as much as it likes to work alone

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News